PYGNX Performance — Payden GNMA Fund, (Investor Class)
Data updated: 2026-09-23
PYGNX returned −0.32% year to date and +3.57% over one year to Jul 2026. Annualised returns are +3.59% over 3 years and −0.46% over 5 years. The fund trailed its Intermediate Securitized Bond category average: $100 invested three years ago grew to $111, against $115 for the category, and to $104 over one year, against $104. Volatility over the past three years was 6.32% a year. In the 12 months to Jul 2026 the fund lost a net $6.8M, and assets reached $79.70M.
PYGNX Growth of $100
What $100 invested in Payden GNMA Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Intermediate Securitized Bond category average over the same months.
| Period | PYGNX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $104 | $104 |
| 3 years (Aug 2023 – Jul 2026) | $111 | $115 |
| 5 years (Aug 2021 – Jul 2026) | $98 | $103 |
| Since data start (Aug 2019 – Jul 2026) | $102 | $111 |
PYGNX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −0.32% |
| 1 year | +3.57% |
| 3 years (annualised) | +3.59% |
| 5 years (annualised) | −0.46% |
PYGNX Annual Returns
Calendar-year total returns of Payden GNMA Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | −0.32% |
| 2025 | +7.53% |
| 2024 | +0.81% |
| 2023 | +4.53% |
| 2022 | −12.57% |
| 2021 | −1.86% |
| 2020 | +4.27% |
| 2019 (Aug–Dec) | +1.06% |
PYGNX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.7% | +1.7% | −1.7% | +0.1% | +0.1% | +0.3% | −1.5% | — | — | — | — | — |
| 2025 | +0.6% | +2.3% | −0.1% | +0.2% | −1.0% | +1.9% | −0.4% | +1.7% | +1.0% | +0.7% | +0.7% | −0.2% |
| 2024 | −0.5% | −1.6% | +1.0% | −2.8% | +1.8% | +1.0% | +2.6% | +1.5% | +1.1% | −2.9% | +1.2% | −1.4% |
| 2023 | +3.0% | −2.4% | +2.0% | +0.5% | −0.9% | −0.5% | 0.0% | −0.9% | −3.2% | −2.1% | +5.1% | +4.2% |
| 2022 | −1.4% | −0.6% | −2.5% | −3.5% | +0.8% | −1.7% | +3.0% | −3.2% | −5.1% | −1.2% | +3.4% | −0.9% |
| 2021 | −0.1% | −0.6% | −0.2% | +0.4% | −0.6% | 0.0% | +0.2% | −0.1% | −0.2% | −0.4% | −0.2% | −0.2% |
| 2020 | +0.5% | +0.9% | +1.8% | +0.6% | +0.2% | −0.1% | −0.2% | 0.0% | −0.2% | +0.2% | +0.3% | +0.2% |
| 2019 | — | — | — | — | — | — | — | +0.9% | +0.1% | +0.3% | −0.1% | −0.1% |
PYGNX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 6.32%
- 3-year Sharpe ratio: -0.14 (vs 4.5% risk-free rate)
- Best month: +5.11% (Nov 2023)
- Worst month: −3.19% (Sep 2023)
PYGNX Fund Flows
Monthly money in and out of Payden GNMA Fund, from SEC Form N-PORT.
- 12-month net flow: −$6.8M
- 12-month gross sales (incl. reinvestments): $6.9M
- Sales ÷ redemptions: 0.50×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $202K | $386K | −$184K |
| Jun 2026 | $407K | $2.2M | −$1.8M |
| May 2026 | $219K | $637K | −$418K |
| Apr 2026 | $1.2M | $492K | $695K |
| Mar 2026 | $316K | $426K | −$110K |
| Feb 2026 | $510K | $1.6M | −$1.1M |
| Jan 2026 | $2.2M | $2.9M | −$730K |
| Dec 2025 | $453K | $731K | −$278K |
| Nov 2025 | $225K | $1.7M | −$1.5M |
| Oct 2025 | $340K | $754K | −$413K |
| Sep 2025 | $611K | $761K | −$149K |
| Aug 2025 | $211K | $1.1M | −$874K |
PYGNX Assets Under Management
Net assets of Payden GNMA Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $79.70M |
| 2026-04-30 | $83.80M |
| 2026-01-30 | $85.10M |
| 2025-10-31 | $87.41M |
| 2025-07-31 | $86.72M |
| 2025-04-30 | $94.64M |
| 2025-01-31 | $94.33M |
| 2024-10-31 | $96.09M |
| 2024-07-31 | $95.55M |
| 2024-04-30 | $99.39M |
| 2024-01-31 | $99.51M |
| 2023-10-31 | $88.35M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.